Photoactive Fluoropolymer Surfaces That Release Sensitizer
Drug Molecules
- Publication date
- Publisher
Abstract
We describe a physical–organic
study of two fluoropolymers
bearing a photoreleasable PEGylated photosensitizer that generates <sup>1</sup>O<sub>2</sub>(<sup>1</sup>Δ<sub>g</sub>) [chlorin e<sub>6</sub> methoxy tri(ethylene glycol) triester]. The surfaces are
Teflon/poly(vinyl alcohol) (PVA) nanocomposite and fluorinated silica.
The relative efficiency of these surfaces to photorelease the PEGylated
sensitizer [shown previously to be phototoxic to ovarian cancer cells
(Kimani, S. et al. <i>J. Org. Chem</i> <b>2012</b>, <i>77</i>, 10638)] was slightly higher for the nanocomposite.
In the presence of red light and O<sub>2</sub>, <sup>1</sup>O<sub>2</sub> is formed, which cleaves an ethene linkage to liberate the
sensitizer in 68–92% yield. The fluoropolymers were designed
to deal with multiple problems. Namely, their success relied not only
on high O<sub>2</sub> solubility and drug repellency but also on the
C–F bonds, which physically quench little <sup>1</sup>O<sub>2</sub>, for singlet oxygen’s productive use away from the
surface. The results obtained here indicate that Teflon-like surfaces
have potential uses in delivering sensitizer and singlet oxygen for
applications in tissue repair and photodynamic therapy (PDT)